CS MEDICA Stock Now Also Traded on XETRA

EQS-News: CS MEDICA A/S / Key word(s): Capital Markets Day
CS MEDICA Stock Now Also Traded on XETRA

01.07.2024 / 12:02 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

The shares of CS MEDICA A/S (ISIN DK0061668225) have been listed on the
Frankfurt Stock Exchange since March 2, 2023. The company, a MedTech pioneer
in the development of medical devices that benefit from bioactive CBD, has
mandated the private bank Hauck Aufhäuser Lampe to include the company's
shares in Deutsche Börse AG's trading venue XETRA and ensure continuous
trading.

As of today, the 12,322,635 registered shares of the company can now also be
traded via the electronic trading system XETRA.

In the electronic trading system XETRA, Designated Sponsors provide
additional liquidity by committing to place binding bid and ask sizes
(so-called quotes) in the order book for the securities they support during
continuous trading and auctions. The private bank Hauck Aufhäuser Lampe
ensures higher liquidity in the stock in this way.

High-quality criteria (minimum requirements) are imposed on Designated
Sponsors by Deutsche Börse AG for liquidity provision. Thereby, the private
bank Hauck Aufhäuser Lampe has achieved the highest rating from Deutsche
Börse ('AA') for years.

"By including our shares in the XETRA trading platform, we offer both
existing and future shareholders an additional trading opportunity," says
Lone Henriksen, CEO of CS MEDICA A/S. "By committing to a Designated
Sponsor, we aim to further increase the liquidity of CS MEDICA stock and
strengthen the free float. This should minimize the spread between bid and
ask prices."


CS MEDICA Group, a Danish MedTech pioneer, specializes in developing
evidence-based, CBD-integrated treatments for pain management, autoimmune
and stress-related disorders. With a focus on patient-centric care, our
products range from innovative R&D to registered over-the-counter
substance-based medical devices and dermaceuticals. Our flagship CANNASEN®
brand, alongside our own-label solutions, exemplifies our dedication to
safe, high-quality treatments for both human and veterinary health globally.

CANNORDIC A/S, a subsidiary of CS MEDICA Group, is a pioneering MedTech
company specializing in innovative substance-based medical devices
containing bioactive CBD. Our dedication to enhancing lives by integrating
innovation, science, technology, and natural cannabis compounds positions it
as a pioneer in the medical technology industry. The company ensures robust
research, development, manufacturing, compliance, data insights, and
commercialization processes.


The group's shares are traded on the stock exchanges and trading platforms
in Frankfurt, Munich, Stuttgart, and XETRA, as well as on the Spotlight
Stock Market in Stockholm under ISIN DK0061668225.


---------------------------------------------------------------------------

01.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        CS MEDICA A/S
                   Indiakaj 10,2
                   2100 Copenhagen
                   Denmark
   Phone:          +45 70707337
   E-mail:         info@cs-medica.com
   Internet:       https://www.cs-medica.com
   ISIN:           DK0061668225
   WKN:            A3CYEQ
   Listed:         Regulated Unofficial Market in Frankfurt, Munich,
                   Stuttgart
   EQS News ID:    1936153

End of News EQS News Service
---------------------------------------------------------------------------

1936153 01.07.2024 CET/CEST